REGINA L JABLONSKI MD NPI 1760486443

NPI Details

Regina L Jablonski, MD is a hematology and oncology internal medicine in Port Jefferson Station, NY with 36 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Regina L Jablonski, MD NPI is 1760486443. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: RUTGERS R W JOHNSON MEDICAL SCHOOL (CAM/NEW BRUNS/PISC)
Graduation Year:1990

The provider's business location address is:

49 NESCONSET HWY
PORT JEFFERSON STATION, NY
ZIP 11776-628
Phone: (631) 751-0000
Fax: (631) 509-6559

The NPI 1760486443 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Phosphate level (HCPCS:84100)
• Magnesium level (HCPCS:83735)
• Uric acid level, blood (HCPCS:84550)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Vitamin d-3 level (HCPCS:82306)
• Protein measurement, serum (HCPCS:84165)
• Red blood count, manual test (HCPCS:85044)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Hemoglobin a1c level (HCPCS:83036)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Ige (immune system protein) level (HCPCS:82785)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Blood test, clotting time (HCPCS:85610)
• Testosterone (hormone) level, total (HCPCS:84403)
• Bilirubin level, total (HCPCS:82247)
• Acute hepatitis panel (HCPCS:80074)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Urinalysis, manual test (HCPCS:81002)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Drawing of blood for a medical problem (HCPCS:99195)
• Injection of drug or substance into vein (HCPCS:96374)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Rheumatoid factor level (HCPCS:86431)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Blood creatinine level (HCPCS:82565)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Liver function blood test panel (HCPCS:80076)
• Albumin (protein) level (HCPCS:82040)
• Phosphatase (enzyme) measurement, acid, total (HCPCS:84060)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Injection, lorazepam, 2 mg (HCPCS:J2060)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Thyroid hormone evaluation (HCPCS:84479)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Blood smear for iron (HCPCS:85536)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)

The enumeration date for this NPI number is 6/9/2005 and was last updated on 1/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.